Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Grace Therapeutics, Inc. (GRCE) had Tangible Shareholders Equity of $13.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.94M |
|
-- |
|
-- |
|
$2.53M |
|
$-2.53M |
|
$1.59M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-0.94M |
|
$-2.53M |
|
$-2.53M |
|
15.93M |
|
15.93M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$17.30M |
|
$0.01M |
|
$49.28M |
|
$66.58M |
|
$1.25M |
|
-- |
|
$2.51M |
|
$3.76M |
|
$62.82M |
|
|
Tangible Shareholders Equity |
$13.55M |
$62.82M |
|
14.13M |
|
| Cash Flow Statement Financials | |
$-4.94M |
|
-- |
|
$-0.33M |
|
$22.13M |
|
$16.86M |
|
$-5.27M |
|
$0.51M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-1.49% |
|
-6.92% |
|
-1.41% |
|
-1.49% |
|
$4.45 |
|
$-0.31 |
|
$-0.31 |
|